CASI Pharmaceuticals, Inc. financial data

Symbol
CASI on Nasdaq
Industry
Pharmaceutical Preparations
Location
1701 1702, China Central Office Tower 1, No. 81 Jianguo Road, Chaoyang District, Beijing, China
State of incorporation
Cayman Islands
Fiscal year end
December 31
Former names
CASI Pharmaceuticals Holdings, Inc. (to 2/14/2023)
Latest financial report
20-F - Q4 2023 - Mar 28, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.4M shares -0.59%
Common Stock, Shares, Outstanding 13.4M shares -0.59%
Common Stock, Value, Issued 1K USD 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.1M USD -63.7%
Accounts Receivable, after Allowance for Credit Loss, Current 9.55M USD -26.4%
Inventory, Net 15.9M USD +159%
Assets, Current 59.3M USD -19.2%
Property, Plant and Equipment, Net 9.24M USD -21.9%
Operating Lease, Right-of-Use Asset 2.39M USD +71.1%
Intangible Assets, Net (Excluding Goodwill) 1.84M USD +73%
Other Assets, Noncurrent 766K USD -27.5%
Assets 75.3M USD -21.8%
Accounts Payable, Current 4.44M USD +34.9%
Liabilities, Current 16.7M USD -1.64%
Operating Lease, Liability, Noncurrent 1.62M USD +239%
Other Liabilities, Noncurrent 15.5M USD +25.9%
Liabilities 51.1M USD +74.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.2M USD -70.7%
Retained Earnings (Accumulated Deficit) -661M USD -3.71%
Stockholders' Equity Attributable to Parent 24.2M USD -45.8%
Liabilities and Equity 75.3M USD -21.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 13.8M shares +0.41%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 61.3M USD -28.3%
Operating Lease, Liability 2.34M USD +74.4%
Lessee, Operating Lease, Liability, to be Paid 2.58M USD +87%
Property, Plant and Equipment, Gross 13.9M USD -1.68%
Operating Lease, Liability, Current 728K USD -16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 505K USD +7.45%
Lessee, Operating Lease, Liability, to be Paid, Year One 727K USD -19.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 238K USD +543%
Lessee, Operating Lease, Liability, to be Paid, Year Three 388K USD +3780%
Deferred Tax Assets, Operating Loss Carryforwards 42.5M USD -35%
Unrecognized Tax Benefits 948K USD -4.92%
Lessee, Operating Lease, Liability, to be Paid, Year Four 350K USD
Additional Paid in Capital 696M USD +0.58%
Deferred Tax Assets, Net of Valuation Allowance 677K USD -73.6%